Dr. Hongqi Tian
Founder, Chairman, Chief Executive Officer
Dr. Hongqi Tian, the founder of Kechow Pharma, has over twenty years of experience in new drug development. During his time at Array Biopharmaceuticals Inc. in the U.S., he successfully developed four new compounds into preclinical and clinical studies. In 2014, he founded Shanghai Kechow Pharma, Inc. The company’s new anti-cancer drug, HL-085, developed with 100% independent intellectual property rights, is regarded as the best of its kind in this field. It is currently undergoing Phase I/II clinical trials simultaneously in China and the U.S. In addition, the drug has applied for more than 80 patents worldwide, with over 40 granted, and has published 40 articles.